Targeting type 1 IFN in immune-mediated inflammatory disease

Building on decades of research, AstraZeneca are starting to unravel complex inflammatory cell signalling pathways and uncover key drivers that cause an imbalance in immune-mediated diseases.

Date: 12 January 2023, 12:00
Venue: Institute of Developmental and Regenerative Medicine (IDRM) IMS-Tetsuya Nakamura Building, Old Road Campus, Roosevelt Dr, Headington, Oxford OX3 7TY and Zoom
Speaker: Dr Hussein Al-Mossawi (AstraZeneca)
Organising department: Medical Sciences Office
Organisers: Sheena Lee (MSD Business Partnerships Office), Medical Sciences Division Business Partnerships Office (University of Oxford)
Organiser contact email address: sheena.lee@medsci.ox.ac.uk
Host: Dr Charlotte Bell (University of Oxford)
Part of: Industry Insight Seminar Series
Booking required?: Required
Booking url: https://www.eventbrite.co.uk/e/industry-insights-seminar-series-tickets-131313804123
Cost: Free
Audience: Members of the University of Oxford and the Biotech/Pharma industry
This talk features in the following public collections:
- Talks of Interest to Medical Sciences
- Innovation & Translation related talks
Editor: Sheena Lee